VANCOUVER, BC--(Marketwire - October 02, 2007) - Upstream Biosciences Inc. (OTCBB: UPBS) today announced that its Chief Executive Officer, Joel L. Bellenson, will unveil Upstream’s promising new drug candidates in a keynote address to the International Scientific Council for Trypanosomiasis Research and Control (ISCTRC) conference being held in Angola from October 1 to 5, 2007.
